SEC Form D · Amendment · filed February 22, 2019
Vergent Bioscience, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Ryan D. Egeland · MINNEAPOLIS, MNDirectorJeffrey Julkowski · MINNEAPOLIS, MNDirector · PromoterJohn Santini · MINNEAPOLIS, MNExec · DirectorJeffrey D. Yurecko · MINNEAPOLIS, MNExecDouglas D. Kohrs · MINNEAPOLIS, MNDirectorRaymond D. Wong · MINNEAPOLIS, MNDirectorSamuel D. Banks · MINNEAPOLIS, MNDirectorDavid R. Schwartz · CHICAGO, ILDirector · PromoterElizabeth C. Fujino · Westlake Village, CADirectorPeter W. Mooradian · Boston, MADirectorPatrick Arippol · Sao Paulo, GuernseyDirectorKyle Volluz · Dallas, TXExecJohn C. Hansen · Westlake Village, CADirectorPhilip H. Lukowski · CHICAGO, ILExec · DirectorCurtis Floyd · BAKERSFIELD, CADirectorBruce Beretta · BAKERSFIELD, CADirectorKevin S. Little · Boca Raton, FLDirector · PromoterNEF Assignment Corporation · Chicago, ILExec · DirectorJason Castle · BAKERSFIELD, CADirectorParamijt Dosanjh · BAKERSFIELD, CAExecAlison Forsyth · Somerville, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗